Articles tagged with “breast-cancer”

Datroway FDA Approval for First-Line Metastatic TNBC

Review the FDA approval of Datroway (datopotamab deruxtecan) for first-line metastatic TNBC. Analyze TROPION-Breast02 efficacy, survival, and safety data.

20 min read

5/16/2026

datroway datopotamab deruxtecan metastatic tnbc fda approval tropion-breast02 trop2 adc breast cancer oncology

Vepdegestrant FDA Approval: First PROTAC for Breast Cancer

Review the 2026 FDA approval of vepdegestrant (Veppanu), the first PROTAC targeted protein degrader for ESR1-mutated breast cancer, and its clinical data.

35 min read

4/28/2026

vepdegestrant protac targeted protein degradation esr1 mutation breast cancer veppanu endocrine resistance oncology